Michael A. Lea

3.9k total citations
139 papers, 2.6k citations indexed

About

Michael A. Lea is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Michael A. Lea has authored 139 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Molecular Biology, 43 papers in Cancer Research and 24 papers in Oncology. Recurrent topics in Michael A. Lea's work include Cancer, Hypoxia, and Metabolism (37 papers), Metabolism, Diabetes, and Cancer (19 papers) and Amino Acid Enzymes and Metabolism (13 papers). Michael A. Lea is often cited by papers focused on Cancer, Hypoxia, and Metabolism (37 papers), Metabolism, Diabetes, and Cancer (19 papers) and Amino Acid Enzymes and Metabolism (13 papers). Michael A. Lea collaborates with scholars based in United States, United Kingdom and Canada. Michael A. Lea's co-authors include George Weber, Nancy B. Stamm, Charles desBordes, Verrell M. Randolph, George H. Weber, Harold P. Morris, E. A. Fisher, Radhey L. Singhal, Michael Koch and Chung S. Yang and has published in prestigious journals such as Science, Journal of Biological Chemistry and Hepatology.

In The Last Decade

Michael A. Lea

136 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael A. Lea United States 28 1.4k 506 321 307 289 139 2.6k
Tim J.B. Gray United Kingdom 32 1.3k 0.9× 626 1.2× 113 0.4× 258 0.8× 195 0.7× 79 3.1k
Ayumi Denda Japan 29 1.0k 0.7× 486 1.0× 225 0.7× 165 0.5× 154 0.5× 114 2.4k
Lois D. Lehman‐McKeeman United States 32 954 0.7× 532 1.1× 164 0.5× 242 0.8× 190 0.7× 93 2.9k
Frederick T. Hatch United States 19 781 0.6× 433 0.9× 599 1.9× 203 0.7× 486 1.7× 30 2.2k
Francesco Feo Italy 37 2.4k 1.7× 828 1.6× 202 0.6× 203 0.7× 193 0.7× 111 3.8k
Yoichi Konishi Japan 32 1.7k 1.2× 944 1.9× 552 1.7× 367 1.2× 118 0.4× 218 3.9k
William E. Fahl United States 35 2.5k 1.7× 486 1.0× 96 0.3× 235 0.8× 97 0.3× 103 3.7k
Shigeaki Sato Japan 33 1.4k 1.0× 1.5k 2.9× 214 0.7× 247 0.8× 190 0.7× 112 3.1k
Jun‐Yan Hong United States 26 1.2k 0.9× 457 0.9× 294 0.9× 176 0.6× 151 0.5× 59 3.0k
Gary M. Williams United States 27 968 0.7× 842 1.7× 334 1.0× 114 0.4× 103 0.4× 74 2.8k

Countries citing papers authored by Michael A. Lea

Since Specialization
Citations

This map shows the geographic impact of Michael A. Lea's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael A. Lea with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael A. Lea more than expected).

Fields of papers citing papers by Michael A. Lea

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael A. Lea. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael A. Lea. The network helps show where Michael A. Lea may publish in the future.

Co-authorship network of co-authors of Michael A. Lea

This figure shows the co-authorship network connecting the top 25 collaborators of Michael A. Lea. A scholar is included among the top collaborators of Michael A. Lea based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael A. Lea. Michael A. Lea is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lea, Michael A., et al.. (2018). Effects of Biguanides on Growth and Glycolysis of Bladder and Colon Cancer Cells. Anticancer Research. 38(9). 5003–5011. 15 indexed citations
2.
Lea, Michael A.. (2014). Growth inhibition of colon cancer cells by compounds affecting AMPK activity. World Journal of Gastrointestinal Oncology. 6(7). 244–244. 24 indexed citations
3.
Lea, Michael A., et al.. (2011). Addition of 2-deoxyglucose enhances growth inhibition but reverses acidification in colon cancer cells treated with phenformin.. PubMed. 31(2). 421–6. 38 indexed citations
4.
Lea, Michael A.. (2010). Alternative Forms of Mortgage Finance: What Can We Learn From Other Countries?. SSRN Electronic Journal. 14 indexed citations
5.
Ludeman, Susan M., et al.. (2002). Exposure to a Deuterated Analogue of Phenylbutyrate Retards S-Phase Progression in HT-29 Colon Cancer Cells. Journal of Pharmaceutical Sciences. 91(4). 1054–1064. 6 indexed citations
6.
Lea, Michael A.. (1996). Organosulfur Compounds and Cancer. Advances in experimental medicine and biology. 401. 147–154. 14 indexed citations
7.
Lea, Michael A. & Nirman Tulsyan. (1995). Discordant effects of butyrate analogues on erythroleukemia cell proliferation, differentiation and histone deacetylase.. PubMed. 15(3). 879–83. 46 indexed citations
8.
9.
Lea, Michael A.. (1993). Regulation of gene expression in hepatomas. International Journal of Biochemistry. 25(4). 457–469. 7 indexed citations
10.
Xiao, Qin, Ilona Jaspers, Elizabeth Matthew, & Michael A. Lea. (1993). Changes in the glucose-6-phosphatase complex in hepatomas. Molecular and Cellular Biochemistry. 122(1). 17–24. 3 indexed citations
11.
Lea, Michael A.. (1992). Action of exogenous differentiating agents on gene expression in cancer cells. Critical Reviews in Oncology/Hematology. 13(3). 189–214. 4 indexed citations
12.
Lea, Michael A., et al.. (1990). Inhibitory effects of orotate on precursor incorporation into nucleic acids. Chemico-Biological Interactions. 75(1). 49–59. 7 indexed citations
13.
Hu, Jennifer J., Karimullah A. Zirvi, & Michael A. Lea. (1990). Combined effect of pH and sodium cyanate on the inhibition of tumor cell proliferation and metabolism by BCNU and hyperthermia. Cancer Chemotherapy and Pharmacology. 26(4). 269–272. 3 indexed citations
14.
Hu, Jennifer J., et al.. (1988). pH-related effects of sodium cyanate on macromolecular synthesis and tumor cell division. Biochemical Pharmacology. 37(11). 2259–2266. 6 indexed citations
15.
Lea, Michael A., et al.. (1988). Selective modulation of nucleotide levels in rat liver and hepatomas by high-orotate or arginine-deficient diets and by carbamoylating agents. Biochimica et Biophysica Acta (BBA) - General Subjects. 964(2). 121–128. 10 indexed citations
16.
Lea, Michael A., et al.. (1987). Chromatin solubilization in rapidly growing hepatomas. Experimental and Molecular Pathology. 47(3). 403–410. 2 indexed citations
17.
Lea, Michael A. & Lawrence Panasci. (1987). Effects of carbamoylating agents on tumor metabolism. Critical Reviews in Oncology/Hematology. 7(4). 329–371. 11 indexed citations
18.
Lea, Michael A., et al.. (1985). Action of cyanate on B16 melanoma. Proceedings of the American Association for Cancer Research. 26. 1 indexed citations
19.
Pezzuto, John M., Michael A. Lea, & Chung S. Yang. (1977). The role of microsomes and nuclear envelope in the metabolic activation of benzo(a)pyrene leading to binding with nuclear macromolecules.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 37(9). 3427–33. 22 indexed citations
20.
Pezzuto, John M., Michael A. Lea, & Chung S. Yang. (1976). Binding of metabolically activated benzo(a)pyrene to nuclear macromolecules.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 36(10). 3647–53. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026